AVROBIO Inc. (AVRO) Misses Q1 EPS by 2c

AVROBIO Inc. (NASDAQ: AVRO) reported Q1 EPS of ($0.57), $0.02 worse than the analyst estimate of ($0.55). Revenue for the quarter came in at $0 versus the consensus estimate of $0 .

For earnings history and earnings-related data on AVROBIO Inc. (AVRO) click here.

You May Also Be Interested In

• Is Treasury selloff a major issue for stock market bulls?
• Huazhu Group Limited (HTHT) Tops Q2 EPS by 37c
• Jasper Therapeutics (JSPR) Tops Q2 EPS by 18c